Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant <em>Acinetobacter baumannii</em> bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality

Abstract

This study demonstrated that an ICU stay and cefoperazone-sulbactam or carbapenem use were seen to be the risk factors associated with the development of CRAB BSI. Critical illness and tigecycline therapy were significantly associated with higher mortality of patients with <i>A. baumannii</i> BSI.